The permission from the U.S. Food and Drug Administration marks Xolair as the basic and lone medication for individuals dealing with one or more food allergies. This arrangement follows clinical exploratory data on the injectable asthma medication, demonstrating its validity in reducing food-related hypersensitivity reactions.